Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

• Siyu Zhang,
• Changxin Huang,
• Yongqiang Li,
• Zhaoyang Li,
• Ying Zhu,
• Lili Yang,
• Haokun Hu,
• Quan Sun,
• Mengmeng Liu,
• Songqiang Cao

Affiliations

Siyu Zhang

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Changxin Huang

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Yongqiang Li

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Zhaoyang Li

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Ying Zhu

Department of Clinical Hematology and Transfusion, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

Lili Yang

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Haokun Hu

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Quan Sun

Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

Mengmeng Liu

Department of Psychiatry and Psychology, 155 Hospital of Kaifeng City, Kaifeng, China

Songqiang Cao

Department of Urology, Huaihe Hospital of Henan University, Kaifeng, China